SCHEMBL30004652

SCHEMBL30004652

CC(C)c1oc(-c2ccc(Cl)cc2Cl)nc1CCC(=O)c1ccc(OCCO)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.50
PPARD Q03181 5/20 0.50
PPARG P37231 4/20 0.50
HPGD P15428 4/20 0.40
NLRP1 Q9C000 1/20 0.40
CYP2C19 P33261 3/20 0.39
POLB P06746 2/20 0.39
CYP2C9 P11712 1/20 0.39
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HSD17B10 Q99714 1/20 0.38
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24742416 1.00 PPARA (0.50) PPARAPPARDPPARGHPGDNLRP1
SCHEMBL24658335 0.94 PPARA (0.55) PPARAPPARDPPARGHPGDNLRP1
SCHEMBL30003540 0.94 PPARA (0.55) PPARAPPARDPPARGHPGDNLRP1
SCHEMBL1765865 0.90 PPARA (0.62) PPARAPPARDPPARGMAPTSMN1; SMN2
SCHEMBL12732439 0.90 PPARA (0.54) PPARAPPARDPPARGHPGDNLRP1
SCHEMBL24658331 0.89 PPARG (0.46) PPARAPPARDPPARGPOLBMAPT
SCHEMBL30003957 0.89 PPARG (0.46) PPARAPPARDPPARGPOLBMAPT
SCHEMBL4754218 0.88 PPARA (0.49) PPARAPPARDPPARGHPGDNLRP1
SCHEMBL24658330 0.87 PPARG (0.48) PPARAPPARDPPARGHPGDMAPT
SCHEMBL24742577 0.87 PPARA (0.51) PPARAPPARDPPARGHPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333379-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2025-10-30 US disclosed
US-12297168-B2 Compounds useful for treating liver diseases ABIONYX PHARMA SA (FR) 2025-05-13 US disclosed
US-20240199575-A1 COMPOUNDS USEFUL FOR TREATING LIVER DISEASES ABIONYX PHARMA SA (FR) 2024-06-20 US disclosed
US-20230278952-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2023-09-07 US disclosed
US-11634387-B2 Compounds useful for treating liver diseases ABIONYX PHARMA SA (FR) 2023-04-25 US disclosed
US-20220363632-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278952-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARD 332/4885PPARG 71/4885
US-20240199575-A1 COMPOUNDS USEFUL FOR TREATING LIVER DISEASES SLC10A1, FABP1, CPT1A PPARA 94/4885PPARD 332/4885PPARG 71/4885
US-11634387-B2 Compounds useful for treating liver diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARD 332/4885PPARG 71/4885
US-20250333379-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARD 332/4885PPARG 71/4885
US-12297168-B2 Compounds useful for treating liver diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARD 332/4885PPARG 71/4885
US-20220363632-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARD 332/4885PPARG 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.